Looking for a Functional Cure
Friday, October 24, 2014ViaCyte, a San Diego-based company, has been working on a combination stem cell-derived product and delivery system that is aiming to treat people with insulin-dependent diabetes.
A Goal to Transform Diabetes Treatment
ViaCyte is developing a transformative cell replacement therapy to free people with insulin-requiring diabetes from painful and frequent insulin injections, strict diet regimens, constant blood sugar monitoring, and serious chronic health conditions associated with the disease.
comments powered by Disqus
